These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 15082222

  • 1. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
    Ryberg H, Söderling AS, Davidsson P, Blennow K, Caidahl K, Persson LI.
    Neurochem Int; 2004 Jul; 45(1):57-62. PubMed ID: 15082222
    [Abstract] [Full Text] [Related]

  • 2. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
    Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Münch G.
    J Neurochem; 2005 Jan; 92(2):255-63. PubMed ID: 15663474
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J, Widl K, Schattauer D, Ludolph AC, Tumani H.
    Neurosci Lett; 2007 Apr 18; 416(3):257-60. PubMed ID: 17368721
    [Abstract] [Full Text] [Related]

  • 4. Axonal damage markers in cerebrospinal fluid are increased in ALS.
    Brettschneider J, Petzold A, Süssmuth SD, Ludolph AC, Tumani H.
    Neurology; 2006 Mar 28; 66(6):852-6. PubMed ID: 16567701
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
    Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H.
    Neurosci Lett; 2006 Sep 01; 404(3):347-51. PubMed ID: 16815630
    [Abstract] [Full Text] [Related]

  • 6. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M, Mogi M, Higaki N, Tateishi T, Ohyagi Y, Horiuchi M, Miki T, Kira JI.
    Acta Neurol Scand; 2009 May 01; 119(5):341-4. PubMed ID: 18798831
    [Abstract] [Full Text] [Related]

  • 7. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
    Perry TL, Krieger C, Hansen S, Eisen A.
    Ann Neurol; 1990 Jul 01; 28(1):12-7. PubMed ID: 2375629
    [Abstract] [Full Text] [Related]

  • 8. Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?
    Mendonça DM, Martins SC, Higashi R, Muscara MN, Neto VM, Chimelli L, Martinez AM.
    Amyotroph Lateral Scler; 2011 Mar 01; 12(2):144-7. PubMed ID: 21198418
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
    Korolainen MA, Pirttilä T.
    Acta Neurol Scand; 2009 Jan 01; 119(1):32-8. PubMed ID: 18547271
    [Abstract] [Full Text] [Related]

  • 10. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases.
    Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, Hayase N, Shiono H, Kobayashi S.
    Ann Neurol; 2000 Apr 01; 47(4):524-7. PubMed ID: 10762167
    [Abstract] [Full Text] [Related]

  • 11. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Scand J Clin Lab Invest; 2007 Apr 01; 67(3):264-9. PubMed ID: 17454840
    [Abstract] [Full Text] [Related]

  • 12. Free amino acid levels in amyotrophic lateral sclerosis.
    Patten BM, Harati Y, Acosta L, Jung SS, Felmus MT.
    Ann Neurol; 1978 Apr 01; 3(4):305-9. PubMed ID: 666270
    [Abstract] [Full Text] [Related]

  • 13. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Rentzos M, Zoga M, Paraskevas GP, Kapaki E, Rombos A, Nikolaou C, Tsoutsou A, Vassilopoulos D.
    J Geriatr Psychiatry Neurol; 2006 Jun 01; 19(2):114-7. PubMed ID: 16690997
    [Abstract] [Full Text] [Related]

  • 14. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
    Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, Buck A, Mash DC.
    Acta Neurol Scand; 2009 Oct 01; 120(4):216-25. PubMed ID: 19254284
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor.
    White LR, Gårseth M, Aasly J, Sonnewald U.
    J Neurosci Res; 2004 Oct 15; 78(2):297-301. PubMed ID: 15378514
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Clin Neurol Neurosurg; 2004 Sep 15; 106(4):289-93. PubMed ID: 15297002
    [Abstract] [Full Text] [Related]

  • 17. Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis.
    Satoi H, Tomimoto H, Ohtani R, Kitano T, Kondo T, Watanabe M, Oka N, Akiguchi I, Furuya S, Hirabayashi Y, Okazaki T.
    Neuroscience; 2005 Sep 15; 130(3):657-66. PubMed ID: 15590150
    [Abstract] [Full Text] [Related]

  • 18. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases.
    Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T.
    J Neurol Sci; 2011 Apr 15; 303(1-2):95-9. PubMed ID: 21292280
    [Abstract] [Full Text] [Related]

  • 19. The role of soluble intercellular adhesion molecules in neurodegenerative disorders.
    Rentzos M, Michalopoulou M, Nikolaou C, Cambouri C, Rombos A, Dimitrakopoulos A, Vassilopoulos D.
    J Neurol Sci; 2005 Feb 15; 228(2):129-35. PubMed ID: 15694193
    [Abstract] [Full Text] [Related]

  • 20. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Watanabe S, Kimura T, Suenaga K, Wada S, Tsuda K, Kasama S, Takaoka T, Kajiyama K, Takeda M, Yoshikawa H.
    J Neurol Sci; 2009 Oct 15; 285(1-2):146-8. PubMed ID: 19595376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.